Response to: Comment on: Eponymous women in ophthalmology: syndromes with prominent eye manifestations named after female physicians – (Response to: Comment on: Eponymous women in ophthalmology: syndromes with prominent eye manifestations named after female physicians, Published online: 2018-12-18; | doi:10.1038/s41433-018-0314-x)
Response to: Comment on: Eponymous women in ophthalmology: syndromes with prominent eye manifestations named after female physicians Response to: Comment on: Eponymous women in ophthalmology: syndromes with prominent eye manifestations named after female physicians, Published online: 18 December 2018; doi:10.1038/s41433-018-0314-x Response to: Comment on: Eponymous women in ophthalmology: syndromes with prominent eye manifestations named after
Kaempferol attenuates retinal ganglion cell death by suppressing NLRP1/NLRP3 inflammasomes and caspase-8 via JNK and NF-κB pathways in acute glaucoma – (Kaempferol attenuates retinal ganglion cell death by suppressing NLRP1/NLRP3 inflammasomes and caspase-8 via JNK and NF-κB pathways in acute glaucoma, Published online: 2018-12-18; | doi:10.1038/s41433-018-0318-6)
Kaempferol attenuates retinal ganglion cell death by suppressing NLRP1/NLRP3 inflammasomes and caspase-8 via JNK and NF-κB pathways in acute glaucoma Kaempferol attenuates retinal ganglion cell death by suppressing NLRP1/NLRP3 inflammasomes and caspase-8 via JNK and NF-κB pathways in acute glaucoma, Published online: 18 December 2018; doi:10.1038/s41433-018-0318-6 Kaempferol attenuates retinal ganglion cell death by suppressing NLRP1/NLRP3
Ophthalmic Safety Alert – Do not use nitrous oxide when there is gas in an operated eye
Intraocular air or gas is often used as a tamponade agent at the end of vitrectomy surgery to secure the retina. The two most common indications are retinal detachment and macular hole surgery. Intraocular gas is also being used increasingly in endothelial keratoplasties (lamellar corneal grafts) initially during the primary procedure or for “rebubbling” dislocated
1-year outcomes of the Xen45 glaucoma implant – (1-year outcomes of the Xen45 glaucoma implant, Published online: 2018-12-14; | doi:10.1038/s41433-018-0310-1)
1-year outcomes of the Xen45 glaucoma implant 1-year outcomes of the Xen45 glaucoma implant, Published online: 14 December 2018; doi:10.1038/s41433-018-0310-1 1-year outcomes of the Xen45 glaucoma implant
Torn from the headlines: role of public awareness and bench- to-bedside research in prevention and treatment of Acanthamoeba keratitis – (Torn from the headlines: role of public awareness and bench- to-bedside research in prevention and treatment of Acanthamoeba keratitis, Published online: 2018-12-14; | doi:10.1038/s41433-018-0306-x)
Torn from the headlines: role of public awareness and bench- to-bedside research in prevention and treatment of Acanthamoeba keratitis Torn from the headlines: role of public awareness and bench- to-bedside research in prevention and treatment of <i>Acanthamoeba</i> keratitis, Published online: 14 December 2018; doi:10.1038/s41433-018-0306-x Torn from the headlines: role of public awareness and bench- to-bedside